Characterization of endothelin synthetic pathways and receptor subtypes: physiological and pathophysiological...

Area of Science:

• Biochemistry
• Pharmacology
• Physiology

Background:

• Endothelins are 21 amino acid peptides with diverse physiological effects, including vascular smooth muscle constriction, mitogenesis, and nervous system function.
• Their production involves a precursor, big endothelin, converted to the active form by an endothelin-converting enzyme (ECE), a metalloprotease.
• At least two endothelin receptors have been identified, exhibiting species-specific distribution and present on various cell types, including smooth muscle, nervous tissue, and epithelial cells.

Purpose of the Study:

• To review the current understanding of endothelins, their production, receptors, and implications in disease.
• To highlight the significance of recent advancements in endothelin research, including the development of receptor antagonists.
• To elucidate the true roles of endothelins in physiological and pathological processes.

Main Methods:

• Review of existing literature on endothelin synthesis, characterization of endothelin-converting enzyme, and identification of endothelin receptors.
• Analysis of the distribution and heterogeneity of endothelin receptors across different species.
• Examination of the therapeutic potential of selective and non-selective endothelin receptor antagonists (e.g., BQ-123, PD 142893, Ro 46-2005).

Main Results:

• Endothelins are potent vasoactive peptides with broad physiological roles beyond vasoconstriction.
• An endothelin-converting enzyme, a metalloprotease inhibited by phosphoramidon, facilitates the conversion of big endothelin to its active form, though other enzymes can also participate.
• Multiple endothelin receptors exist with varied tissue distribution and species-specific heterogeneity, offering potential therapeutic targets.

Conclusions:

• Endothelins are implicated in various disease states, necessitating further investigation into their precise roles.
• The development of endothelin receptor antagonists provides crucial tools for elucidating these roles and exploring therapeutic applications.
• Continued research is essential to fully understand the complex functions of endothelins and their clinical significance.